Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-02-22 | OCULAR THERAPEUTIX, INC | Dugel Pravin
(Executive Chairman) |
A | Common Stock | A | 854979 | $0.00 - $0.00 | $0 |
2024-02-22 | OCULAR THERAPEUTIX, INC | Nayak Sanjay
(Chief Strategy Officer) |
A | Common Stock | A | 80300 | $0.00 - $0.00 | $0 |
2024-02-05 | OCULAR THERAPEUTIX, INC | White Christopher G
(Chief Business Officer) |
S | Common Stock | A | 5910 | $4.86 - $4.86 | $28,722 |
2024-02-03 | OCULAR THERAPEUTIX, INC | White Christopher G
(Chief Business Officer) |
A | Common Stock | A | 39980 | $0.00 - $0.00 | $0 |
2024-02-05 | OCULAR THERAPEUTIX, INC | Strassburger Phil...
(General Counsel) |
S | Common Stock | A | 6029 | $4.86 - $4.86 | $29,300 |
2024-02-03 | OCULAR THERAPEUTIX, INC | Strassburger Phil...
(General Counsel) |
A | Common Stock | A | 58304 | $0.00 - $0.00 | $0 |
2024-02-05 | OCULAR THERAPEUTIX, INC | Ozden Rabia Gurses
(Chief Medical Officer) |
S | Common Stock | A | 6346 | $4.86 - $4.86 | $30,841 |
2024-02-03 | OCULAR THERAPEUTIX, INC | Ozden Rabia Gurses
(Chief Medical Officer) |
A | Common Stock | A | 66633 | $0.00 - $0.00 | $0 |
2024-02-05 | OCULAR THERAPEUTIX, INC | Notman Donald
(Chief Financial Officer) |
S | Common Stock | A | 6212 | $4.86 - $4.86 | $30,190 |
2024-02-03 | OCULAR THERAPEUTIX, INC | Notman Donald
(Chief Financial Officer) |
A | Common Stock | A | 61636 | $0.00 - $0.00 | $0 |
2024-02-05 | OCULAR THERAPEUTIX, INC | Mattessich Antony C.
(President and CEO) |
S | Common Stock | A | 19642 | $4.86 - $4.86 | $95,460 |
2024-02-03 | OCULAR THERAPEUTIX, INC | Mattessich Antony C.
(President and CEO) |
A | Common Stock | A | 180400 | $0.00 - $0.00 | $0 |
2024-01-31 | OCULAR THERAPEUTIX, INC | Notman Donald
(Chief Financial Officer) |
S | Common Stock | D | 6433 | $4.95 - $4.95 | $31,843 |
2024-01-31 | OCULAR THERAPEUTIX, INC | Ozden Rabia Gurses
(Chief Medical Officer) |
S | Common Stock | D | 7764 | $4.95 - $4.95 | $38,431 |
2024-01-31 | OCULAR THERAPEUTIX, INC | Strassburger Phil...
(General Counsel) |
S | Common Stock | D | 6831 | $4.95 - $4.95 | $33,813 |
2024-01-31 | OCULAR THERAPEUTIX, INC | White Christopher G
(Chief Business Officer) |
S | Common Stock | D | 5147 | $4.95 - $4.95 | $25,477 |
2024-01-31 | OCULAR THERAPEUTIX, INC | Mattessich Antony C.
(President and CEO) |
S | Common Stock | D | 18338 | $4.95 - $4.95 | $90,773 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |